Ticker
MGNXCompany Name
MACROGENICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 102.39M | $ 231K | $ 69.67M | $ 0 | -68.27% |
3/31/2025 | $ 97.16M | $ 796K | $ 0 | $ 0 | -0.82% |
12/31/2024 | $ 132.49M | $ 3.44M | $ 0 | $ 0 | -2.59% |
9/30/2024 | $ 236.62M | $ 3.55M | $ -1K | $ 0 | -1.5% |
6/30/2024 | $ 228.31M | $ 3.6M | $ 50M | $ 0 | -23.47% |
3/31/2024 | $ 918.83M | $ 3.19M | $ 49.84M | $ 0 | -5.77% |
12/31/2023 | $ 1.28B | $ 1.17M | $ 149.5M | $ 0 | -11.77% |
9/30/2023 | $ 337.44M | $ 2.24M | $ 149.5M | $ 0 | -44.97% |
6/30/2023 | $ 308.51M | $ 2.2M | $ 99.5M | $ 0 | -32.97% |
3/31/2023 | $ 444M | $ 2.24M | $ 99.66M | $ 0 | -22.95% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for MACROGENICS INC is calculated as follows: (-1 * CF - Equity [ $ 175.55M ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ 0 ]) / Market Cap [ $ 1.18B ]
(=) Shareholder Yield [ -14.83% ]
Minimum
Jun 30, 2025
Maximum
Sep 30, 2022
Average
Median
filtered constituents | 3.48K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.58% |
median | 1.07% |
std | 11.13% |